Back to search

Marshall University

Dexmedetomidine adjunctive ketamine to enhance attenuation of methamphetamine-induced agitation

Abstract

dc:description.abstract

Agitation caused by methamphetamine (METH) use is a common and serious issue in emergency settings. While sedatives like benzodiazepines are often used, they can be dangerous, especially when breathing is already compromised due to METH-opioid co-exposure. Dexmedetomidine (DEXMED) is a safer alternative that provides sedation without major effects on breathing, but it can lower heart rate and blood pressure when used at high doses. This thesis project focused on finding whether combining low-dose DEXMED with ketamine (KET) can safely and effectively manage METH-induced agitation in a rat model. Using METH to trigger hyperactivity, we will test whether this combination could reduce agitation and offer better sedation than DEXMED alone while possibly yielding a more so ideal side effect profile than that of higher DEXMED doses.

Degree

thesis:*
Name thesis:degree_name
Pharmaceutical Sciences
Level thesis:degree_level
Thesis
Discipline thesis:degree_discipline
School of Pharmacy

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Budamkayala, Madhuri
Contributors dc:contributor
  • Dr. Michael Hambuchen
  • Dr. Cynthia B Jones
  • Dr. Eric Blough

Subjects

dc:subject × 8

Identifiers

dc:identifier.*
Repository record dc:identifier
https://mds.marshall.edu/etd/1998

Chain of custody

source
Harvested from
Marshall University
Base URL
mds.marshall.edu/do/oai/
Last updated
2026-11-21
Source record
OAI-PMH GetRecord
citation

Budamkayala, Madhuri. Dexmedetomidine adjunctive ketamine to enhance attenuation of methamphetamine-induced agitation. Thesis thesis, https://mds.marshall.edu/etd/1998